This percentage increased for FGFR1‐15R and FGFR1‐25Ra 30 min after FGF‐2‐treatment as compared with FGFR1‐WT confirming previous data on enhanced recycling capabilities of FGFR1‐15R and FGFR1‐25Ra in tumor cells. The gene discussed is FGF2; the disease is neoplasm.